1. Home
  2. GHLD vs ADPT Comparison

GHLD vs ADPT Comparison

Compare GHLD & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHLD
  • ADPT
  • Stock Information
  • Founded
  • GHLD 1960
  • ADPT 2009
  • Country
  • GHLD United States
  • ADPT United States
  • Employees
  • GHLD N/A
  • ADPT N/A
  • Industry
  • GHLD Finance: Consumer Services
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GHLD Finance
  • ADPT Health Care
  • Exchange
  • GHLD Nasdaq
  • ADPT Nasdaq
  • Market Cap
  • GHLD 867.0M
  • ADPT 929.8M
  • IPO Year
  • GHLD 2020
  • ADPT 2019
  • Fundamental
  • Price
  • GHLD $12.74
  • ADPT $6.81
  • Analyst Decision
  • GHLD Buy
  • ADPT Buy
  • Analyst Count
  • GHLD 5
  • ADPT 4
  • Target Price
  • GHLD $16.00
  • ADPT $6.75
  • AVG Volume (30 Days)
  • GHLD 14.1K
  • ADPT 1.3M
  • Earning Date
  • GHLD 03-11-2025
  • ADPT 02-12-2025
  • Dividend Yield
  • GHLD 3.92%
  • ADPT N/A
  • EPS Growth
  • GHLD N/A
  • ADPT N/A
  • EPS
  • GHLD N/A
  • ADPT N/A
  • Revenue
  • GHLD $829,864,000.00
  • ADPT $177,282,000.00
  • Revenue This Year
  • GHLD $37.55
  • ADPT $6.48
  • Revenue Next Year
  • GHLD $29.77
  • ADPT $18.72
  • P/E Ratio
  • GHLD N/A
  • ADPT N/A
  • Revenue Growth
  • GHLD 4.51
  • ADPT N/A
  • 52 Week Low
  • GHLD $11.21
  • ADPT $2.28
  • 52 Week High
  • GHLD $18.26
  • ADPT $7.46
  • Technical
  • Relative Strength Index (RSI)
  • GHLD 38.30
  • ADPT 54.92
  • Support Level
  • GHLD $12.44
  • ADPT $5.98
  • Resistance Level
  • GHLD $13.69
  • ADPT $7.28
  • Average True Range (ATR)
  • GHLD 0.66
  • ADPT 0.54
  • MACD
  • GHLD -0.10
  • ADPT -0.00
  • Stochastic Oscillator
  • GHLD 44.22
  • ADPT 58.06

About GHLD Guild Holdings Company

Guild Holdings Co is a growth-oriented mortgage company. It operates in two segments; The origination segment operates its loan origination business throughout the United States. It is responsible for loan origination, acquisition, and sale activities. This segment is further divided into retail and correspondent channel, and The servicing segment provides a steady stream of cash flow to support the origination segment more importantly it allows for the Company to build long-standing client relationships that drive repeat and referral business back to the origination segment to recapture the client's next mortgage transaction. It is responsible for the servicing activities of all loans in its servicing portfolio. It generates a majority of its revenue from the Origination segment.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Share on Social Networks: